Trial Profile
A retrospective study of vedolizumab therapy in real-world clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 25 Feb 2016 New trial record